SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Masterpiece Technology Group, Inc. (MPTG)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kenneth V. McNutt who wrote (7)2/16/2000 1:04:00 AM
From: Bill Purcell  Read Replies (1) of 16
 
Here'e why I originally bought in:

OTC BB: MPTG

Recent Price: $2.50
52-Week Range: $1.0625 to $6.5625
Outstanding shares: 3.03 million
Estimated Float: 1.15 million
Market Cap: $7.50 million
Held by Insider and Management: 62%
2000 projected revenues: $10 million
2000 projected EPS: $0.31 per share
Rating: Strong Buy
6 to 24-month Target Price: $10-$15
Company Website: mptg.org

INVESTMENT SUMMARY

- We rate MPTG a "strong buy" for both conservative and aggressive
investors. A supreme opportunity of immense profits has been caught in
the making. Investor's fundamental and technical dream come true. MPTG
has been growing at a geometric rate for most of 1999 and the foundation
has been laid for spectacular company developments in the near future.
MPTG is positioning itself to become an important force in the electronic
data storage. MPTG provides a suite of comprehensive software and
technical software solutions for medical office management, physician
financial and clinical outcome analysis and medical practice guidelines.
MPTG is involved in the fastest growing and hottest sector of the economy,
Internet, e-commerce, electronic data storage, systems software, an
industry with a growth rate of 33% per year expected for the next decade.
The company is leading the way into millennium by identifying, funding ,
developing, and managing evolving and emerging technology.

- MPTG is at the forefront of the digital information revolution. The
Company offers cutting-edge software in document management, digital
imaging and digital archival management with a heavy emphasis on medical
information management. The market is estimated to exceed $1 billion in
total annual revenues.

- MPTG is undergoing major developments in new technology, new
acquisitions and alliances.

- After growing quickly during this year, the resulting profit by end of
year 2000 is projected to be $1.1 million or $0.31 per share on the basis
of 3.5 million outstanding shares. Comparable public companies are
currently commanding PE ratios from 50 to 60. In order to reach a similar
market valuation, MPTG stock price would reach $15 to $18 in the next two
years.

THE COMPANY PROFILE

Masterpiece Technology Group, Inc. (OTC BB: MPTG) is a ten-year old
business and healthcare systems company currently serving industry leading
clients such as Gillette, LensCrafters and Morgan Stanley Dean Witter.
The Company designs, develops, markets and supports medical document
management systems and personal productivity software which facilitates
the recording, imaging, manipulation, distribution and storage of
paper-based medical information on personal and network computers using
Microsoft Windows and Windows NT operating systems.

Maplecrest Custom Software (http://www.maplecrest.com):

- Maplecrest Healthcare Systems: Maplecrest EMR is a unique cutting edge,
32 bit Windows NT electronic medical records software that combines the
best of the original guideline/outcomes driven Masterpiece system and the
expertise of the Maplecrest programming staff. This combination has
produces one of the most robust and comprehensive EMR software systems
available. As the company moves towards the technology based, web-enabled
paperless office, Maplecrest EMR expects to set the pace.

- Maplecrest Business Systems: DocPrep Studio from Maplecrest Software is
a corporate enterprise document publishing solution designed to
revolutionize the way you publish your documents and communicate with your
customers. Today, a real competitive advantage lies in efficient document
publishing that can improve
your customer communications while reducing your costs. And, that's
exactly what DocPrep Studio is designed to do.

- DocPrep Studio is much more than your standard document publishing
software. It's an innovative system designed to help you create the most
professional and highly personalized customer communication materials. And
it's a program that allows you to respond quickly to your customers' needs
by automatically publishing and distributing your documents anywhere in
your organization including the Internet. There is no other document
publishing solution this smart, this fast or this flexible.

Triadd Software Corporation (http://www.triaddsoftware.com/):

Triadd Software Corporation develops and sells proprietary software for
the records management market. Founded in 1989, Triadd presently services
over 200 accounts primarily in the manufacturing, government, service,
utilities and financial markets. Many of the Company's customers are
Fortune 1000 class customers and similar sized governmental agencies.
Triadd has a strong sales growth record with an annual average sales
increase of 32% over the past 4 years.

Triadd has developed and sells a proprietary computer software package
named GAIN. This product has the capability to manage active and inactive
records of organizations of all sizes. Additionally, Triadd sells bar code
equipment that is compatible with Triadd's software product. A major
factor contributing to the uniqueness of the GAIN system is its ability to
manage the retention policy of all types of records. While some systems
can do it for paper-based records, GAIN can do it for paper, electronic,
and image-based
records.

Current Client Base:

A&M Products, Abraham & London, Air Age Publishing, AllTel Information
Services, Atlantic Star, Banta, Boehringer Ingelheim, Bridgeport Surgical,
Brinks, Inc., Clorox Corporation, Compaq Corporation, Congressional
Abstract, Danbury Surgical, Denver Spine & Rehabilitation, Dunmore
Corporation, Duracell, First Brands, Inc., GEOTA, GMAC, GTE
Communications, IBS, Lender?s Service, Inc., LensCrafters, Matson
Financial Advisors, Inc., Merrill-Lynch Credit Corporation, Online
Documents, Inc., Pitney Bowes, STP Products, System Rx, The Beekley
Corporation, The Gillette Company, Vectron Labs.

INVESTMENT OPINION

MPTG is focused on the emerging growth opportunity within the digital
infrastructure sectors including a strong technological emphasis on
medical information management. The Company's strategic focus rests upon
its ability to identify and acquire private companies with technologies
and marketing mechanisms that work in concert with MPTG?s. To date,
MPTG?s acquisition of Maplecrest and Triadd Software and several other
strategic companies which are being studied as acquisition candidates ?
all should build MPTG?s technology portfolio as a powerful, robust fully
web-enabled global information solution for the next century.

We view MPTG as an excellent growth company with exceptional potential for
capital appreciation over both the immediate and longer term. As industry
and investor awareness of MPTG increases and additional acquisitions and
alliances are announced, MPTG's shares should move much higher in the
coming months.

Bearing in mind that significant company developments have and will occur
this year, along with industry projections, leads us to believe that MPTG
is an excellent investment opportunity. MPTG has aggressive plans to
become a leader in the emerging e-commerce and electronic data industries.

MPTG has planned increases in sales, distribution and implementation of
their product mix in targeted U.S., South African, European and Canadian
markets. Anticipated sales for 1999 should exceed $4 million with 2000
revenues anticipated to exceed $10 million. The resulting profit by end
of year 2000 is projected by us to be $1.1 million or $0.31 per share on
the basis of 3.5 million outstanding shares with revenues at $10 million.
Comparable public companies are currently commanding PE ratios from 50 to
60. In order to reach a similar market valuation, MPTG stock price would
reach $15 to $18 in the next two years. We believe the stock is highly
attractive to both aggressive and conservative investors and therefore
rate this stock a strong buy.

We believe that MPTG story has not yet come out and come to the attention
of the investment community. It's extremely undervalued when we consider
its huge potential in the emerging and high growth industry. By the time
the investment community wakes up to what's happening at MPTG, the share
price could easily be well over $4.00 per share. We have an absolute
ground floor opportunity to get in before the institutions and fund
managers find the stock. Therefore, MPTG is rated "strong buy" with a 6
to 24-month target price at $10-$15.
-------------------------------------------------------
Disclaimer: Special Report, published by analystgroup.com is an
independent electronic publication providing information and factual
analysis on selected companies. All statements and expressions are
the opinion of analystgroup.com and are not meant to be either
investment advice or a solicitation or recommendation to buy, sell, or
hold securities. Investing in micro-cap securities is highly speculative
and carries an extremely high degree of risk.
analystgroup.com is not a registered investment advisor or a broker
dealer. It is possible that an investor's investment may be lost or
impaired due to the speculative nature of the companies profiled.
Special Report relies on information provided by the featured
Companies and/or Edgar filings. While analystgroup.com believes its
sources to be reliable, associates of analystgroup.com, or any
affiliated parties make no representation or warranty as to the
accuracy of the information provided. Readers should not rely solely
on the information contained in this publication, but should consult
with their own independent tax, business and financial advisors with
respect to any investment opportunity, including any contemplated
investment in the advertised Company.

Factual statements in this publication are made as of the date stated
and are subject to change without notice. analystgroup.com is not
responsible for any claims made by the Company. We have prepared this
report, drawing upon a range of public news, the company's website and
information from sources in the industry, as well as data and opinions
provided by the company. Prior to issuing this report, the Company
reviewed and approved the contents in writing hereof. analystgroup.com
has not independently verified the Company's representations. Any
opinions expressed in this report are statements of judgment as of the
date of publication. We urge readers to carefully verify all
presentations within the report independently. The receipt of this
publication shall not create, under any circumstances, any implication
that there has been no change in the affairs of the company profiled since
the date of review. This advertisement does not provide an analysis of
the Company's financial position. analystgroup.com of this advertisement
has been paid 10,000 free trading shares of MPTG's common stock for the
preparation and electronic dissemination of this report by Internatinal
Reserve Group. This compensation should be viewed as a potential conflict
of interest. Furthermore, associates of analystgroup.com may have stock
positions on profiled companies from time to time. We may profit in the
event the shares of the Company profiled by us increase in value. These
positions may be liquidated from time to time even after we have made
positive comments regarding the Company. The receipt of this information
constitutes your acceptance of these terms and conditions.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS: Except for historical
information contained herein, the statements on this website and
newsletter are forward-looking statements that are made pursuant to the
safe harbor provisions of the Private Securities Reform Act of 1995.
Forward-looking statements involve known and unknown risks and
uncertainties, which may cause a company's actual results in the future
periods to differ materially from forecasted results. These risks and
uncertainties include, among other things, product price volatility,
product demand, market competition and risk inherent in the companies
operations. You can identify these statements by the fact that they do
not relate strictly to historical or current facts. They use words such
as ``anticipate,' ``estimate,' ``expect,' ``project,' ``intend,'
``plan,", "anticipate", "guess", "think", "hear", "suggest", ``believe,'
"will", "would", "should" and other words and terms of similar meaning in
connection with any discussion of future operating or financial
performance.

As a suggestion, "Never, ever, make an investment based solely on what you
read in an online newsletter or Internet bulletin board, especially if the
investment involves a small, thinly-traded company that isn't well known,"
said Nancy M. Smith, Director of SEC's Office of Investor Education and
Assistance. "Assume that the information about these companies is not
trustworthy unless you can prove otherwise through your own independent
research." "Internet Fraud" is available on the SEC's Web Site, at
sec.gov.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext